Pancreatic cancer is one of the most fatal malignancies. Palliative care represents an important aspect of management in patients with pancreatic malignancy. Identifying and treating disease related symptoms are very important. As a physician taking care of these patients it is essential to know these symptoms and treatment modalities. Common problems include biliary obstruction, anticoagulation, and pain management. This review discusses the data presented at the 2011 American Society of Clinical Oncology (ASCO) Annual Meeting symptom management and supportive care strategies including Abstracts #e14665, #e14622, and #LBA9014. Success is needed in managing these symptoms to palliate patients with advanced pancreatic cancer. It is important...
Introduction: Pancreatic cancer is a highly lethal disease with a close association between incidenc...
Our objective was to examine the impact of palliative care (PC) on aggressive care near death for pa...
Objective Pancreatic cancer has poor survival rates due to non-specific symptoms leading to later di...
Pancreatic cancer is one of the most lethal malignancies. An estimated 32,300 patients will die of p...
Pancreatic cancer commonly diagnosed at late stage due to subtle clinical manifestation and associat...
Patients with advanced pancreatic cancer (APC) experience many disease-related symptoms. ESAS-r meas...
Most patients with pancreatic cancer will present with metastatic or locally advanced disease. Unfor...
The management of patients with advanced pancreatic cancer often requires a multi-disciplinary appro...
To receive a diagnosis of pancreatic cancer can lead to a tremendous change in a person’s life. Thou...
PURPOSE: We evaluated the attitude in using chemotherapy near the end of life in advanced pancreatic...
Purpose: Despite the benefits of palliative care (PC) in pancreatic cancer, little is known about pa...
Between 70 and 90 percent of patients with pancreatic cancer will present with jaundice, and 90 % wi...
WOS: 000282621800019PubMed ID: 20941825Purpose: The symptoms and survival of patients with advanced ...
Pancreatic cancer, as the 4th leading cause of cancer death in the U.S., remains a challenging disea...
Background: Pancreatic cancer has a dire prognosis and is associated with a high mortality. Palliati...
Introduction: Pancreatic cancer is a highly lethal disease with a close association between incidenc...
Our objective was to examine the impact of palliative care (PC) on aggressive care near death for pa...
Objective Pancreatic cancer has poor survival rates due to non-specific symptoms leading to later di...
Pancreatic cancer is one of the most lethal malignancies. An estimated 32,300 patients will die of p...
Pancreatic cancer commonly diagnosed at late stage due to subtle clinical manifestation and associat...
Patients with advanced pancreatic cancer (APC) experience many disease-related symptoms. ESAS-r meas...
Most patients with pancreatic cancer will present with metastatic or locally advanced disease. Unfor...
The management of patients with advanced pancreatic cancer often requires a multi-disciplinary appro...
To receive a diagnosis of pancreatic cancer can lead to a tremendous change in a person’s life. Thou...
PURPOSE: We evaluated the attitude in using chemotherapy near the end of life in advanced pancreatic...
Purpose: Despite the benefits of palliative care (PC) in pancreatic cancer, little is known about pa...
Between 70 and 90 percent of patients with pancreatic cancer will present with jaundice, and 90 % wi...
WOS: 000282621800019PubMed ID: 20941825Purpose: The symptoms and survival of patients with advanced ...
Pancreatic cancer, as the 4th leading cause of cancer death in the U.S., remains a challenging disea...
Background: Pancreatic cancer has a dire prognosis and is associated with a high mortality. Palliati...
Introduction: Pancreatic cancer is a highly lethal disease with a close association between incidenc...
Our objective was to examine the impact of palliative care (PC) on aggressive care near death for pa...
Objective Pancreatic cancer has poor survival rates due to non-specific symptoms leading to later di...